Nicholas Investment Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Nicholas Investment Partners’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-67,842	Closed	-$1.02M	–	307
2016 Q4	$1.02M	Sell	67,842 -7,025	-9%	-$98.6K	0.08%	253
2016 Q3	$940K	Buy	+74,867	New	+$751K	0.06%	287
2014 Q3	–	Sell	-105,235	Closed	-$1.77M	–	340
2014 Q2	$1.77M	Buy	105,235 +1,620	+2%	+$29.2K	0.1%	249
2014 Q1	$2.08M	Buy	103,615 +75,445	+268%	+$1.63M	0.17%	202
2013 Q4	$546K	Buy	+28,170	New	+$498K	0.04%	293

Other funds holding OXFD

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Nicholas Investment Partners's OXFD Position: Q1 2017 in Review

Nicholas Investment Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2017, closing a stake of 67,842 shares — an estimated $1.02M sold.

Nicholas Investment Partners first reported a position in OXFD in Q4 2013 and held it in 5 quarters. The position peaked at $2.08M in Q1 2014. 80 funds tracked by Wall St. Rank hold OXFD as of Q1 2017.

Nicholas Investment Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2017 after selling out during the quarter.
Nicholas Investment Partners sold 67,842 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2017, an estimated $1.02M.
Nicholas Investment Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 5 quarters.
Nicholas Investment Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.08M in Q1 2014.
80 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2017.

Based on Nicholas Investment Partners's 13F filing for Q1 2017, filed 15 May 2017.